Poly-ubiquitination in TNFR1-mediated necroptosis by Dondelinger, Yves et al.
MULTI-AUTHOR REVIEW
Poly-ubiquitination in TNFR1-mediated necroptosis
Yves Dondelinger1,2 • Maurice Darding3 • Mathieu J. M. Bertrand1,2 • Henning Walczak3
Received: 14 March 2016 / Accepted: 18 March 2016 / Published online: 11 April 2016
 The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract Tumor necrosis factor (TNF) is a master pro-
inflammatory cytokine, and inappropriate TNF signaling is
implicated in the pathology of many inflammatory diseases.
Ligation of TNF to its receptor TNFR1 induces the transient
formation of a primary membrane-bound signaling complex,
known as complex I, that drives expression of pro-survival
genes. Defective complex I activation results in induction of
cell death, in the form of apoptosis or necroptosis. This
switch occurs via internalization of complex I components
and assembly and activation of secondary cytoplasmic death
complexes, respectively known as complex II and necro-
some. In this review, we discuss the crucial regulatory
functions of ubiquitination—a post-translational protein
modification consisting of the covalent attachment of ubiq-
uitin, and multiples thereof, to target proteins—to the various
steps of TNFR1 signaling leading to necroptosis.
Keywords Ubiquitination  Necroptosis  TNFR1 
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Introduction
Host defense against invading microbes is mediated by the
selective sensing of some of their conserved components
by an array of innate immune receptors that are mainly
expressed by cells of the immune system and barrier cells
that line the outside world. Recognition of these so-called
pathogen-associated molecular patterns (PAMPs) by the
pattern recognition receptors (PRRs) leads to the activation
of signaling pathways [including the mitogen-activated
protein kinase (MAPK) and nuclear factor-jB (NF-jB)
pathways] that collectively drive the production and release
of pro-inflammatory cytokines and chemokines [1]. These
cytokines can modulate the innate immune response by
binding to different plasma membrane receptors, including
members of the tumor necrosis factor receptor superfamily
(TNFR-SF). In addition to their ability to further induce
inflammatory mediators, some TNFR-SF members known
as death receptors (DRs) possess a cytoplasmic death
domain (DD) that allows them to transduce a regulated pro-
death signal resulting in apoptotic or necroptotic death of
the cell [2]. The combination of inflammatory cytokine
production and activation of cell death pathways alerts the
immune system and clears the potentially harmful
microbes from the organism. Although crucial for the
protection of the organism from microbial insult, the
inflammation response needs tight regulation because
inappropriate inflammatory signals and excessive cell
death are at the origin of various pathologies.
Ubiquitination, a post-translational modification of
proteins consisting in the covalent attachment of the small
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8 kDa protein ubiquitin (Ub), and multiples thereof, to
target proteins, plays a crucial role in the regulation of
various aspects of the inflammatory response [3]. Ubiqui-
tination is a dynamic process that is catalyzed by the action
of a three-step enzymatic cascade involving a Ub-activat-
ing enzyme (E1), a Ub-conjugating enzyme (E2) and a Ub-
ligase (E3), and which is negatively regulated by de-
ubiquitinases (DUBs). Ubiquitin is first loaded on the E1 in
an ATP-dependent manner. Next, Ub is discharged from
the E1 and transferred to the E2. The E2 can then bind to an
E3 that mediates the transfer of Ub to a lysine (K) residue
of a substrate via an isopeptide bond. The attachment of a
single moiety of Ub to a target protein is referred to as
mono-ubiquitination. Since Ub itself contains seven lysine
residues (K6, K11, K27, K29, K33, K48 and K63) that can
all serve as acceptor sites for another Ub molecule, ubiq-
uitination can also result in the conjugation of at least
seven different poly-Ub chains to a substrate. An additional
chain, known as the M1-linked poly-Ub chain (also called
linear Ub chain) can be generated via a peptide bond
between the N-terminal methionine (M1) of one Ub to the
C-terminal glycine of another [4–6]. The Linear UBiquitin
chain Assembly Complex (LUBAC) is the only E3 iden-
tified so far capable of exclusively generating these M1-
linked ubiquitin linkages. Because the internal lysines of
Ub are present in different positions on the surface of the
protein, each of the eight possible Ub linkages adopts a
structurally distinct conformation [7]. Proteins harboring
Ub-binding domains (UBDs) specifically recognize these
structurally different Ub linkages, and thereby translate the
Ub code into distinct cellular functions [8]. De-ubiquiti-
nases terminate or modulate the Ub-dependent signal by
removing the Ub moieties from the substrates. Two major
classes of DUBs exist: substrate-specific DUBs and link-
age-specific DUBs [9]. The specificity of the former class
is regulated by substrate recognition and the enzymes that
constitute that group are usually able to cleave any type of
linkage. Most members of the Ub-specific protease (USP)
family are considered substrate-specific DUBs. In contrast,
the other families of DUBs are mainly linkage-specific and
are able to process only few specific types of Ub linkages.
For both DUB types, substrate specificity can be further
regulated by the presence of additional UBDs, the binding
to UBD-containing adaptor proteins and post-translational
modifications [9].
It is evident that the spatiotemporal regulation of the
expression and/or activity of all these different types of Ub-
modulating enzymes tightly controls the intracellular Ub
code and, as a consequence, also the cellular response to a
specific trigger. Indeed, interfering with E3s and DUBs
greatly affects the responses activated downstream of
several innate immune receptors. In this review, we focus
on the TNF signaling pathway and discuss the literature on
the role of ubiquitination in the regulation of TNF-medi-
ated necroptosis, a caspase-independent regulated form of
necrosis. During this cell death process, and in contrast to
apoptosis, the cell and its organelles swell until this process
finally culminates in plasma membrane rupture and cell
death. TNF-mediated necroptosis relies on RIPK1 kinase-
dependent assembly of a cytosolic death complex, known
as the necrosome, whose core components apart from
RIPK1 are RIPK3 and MLKL [10–13]. The necrosome
presumably originates from the dissociation of a primary
plasma membrane-associated signaling complex, called
TNFR1 complex I or TNRF1-SC, which forms within
seconds following engagement of TNFR1 by TNF [14, 15].
It is therefore important to start our review by describing
the role of ubiquitination in the regulation of TNFR1
complex I assembly and function.
Role of poly-ubiquitination in regulating TNFR1
complex I assembly
Binding of TNF to TNFR1 induces the independent
recruitment of the adaptor protein TRADD and the kinase
RIPK1 to the receptor’s DD via homotypic DD interactions
(Fig. 1). Complex I-recruited TRADD serves as platform
for recruitment of TRAF2 and/or TRAF5. The cIAP
interaction motif (CIM) contained within TRAF2 allows
recruitment of two closely related members of the Inhibitor
of Apoptosis Protein (IAP) family, the Ub E3s cIAP1 and
cIAP2 [16, 17]. Following their recruitment, cIAP1/2
ubiquitinate components of complex I, such as RIPK1 and
cIAP1 itself, with K63-, K11- and K48-linked poly-Ub
chains [18–23]. The Ub chains generated by cIAP1/2 in
turn allow the subsequent recruitment of LUBAC, a Ub E3
complex consisting of the central catalytic component
HOIP (RNF31), HOIL-1 (RBCK1) and SHARPIN (SIPL1)
that exclusively generates M1-linked poly-Ub chains [17,
23–26]. LUBAC adds M1-linked Ub chains to components
of complex I, including RIPK1, NEMO, TRADD and
TNFR1 itself [17, 23, 26–28]. The Ub chains placed on
components of complex I by cIAP1/2 and LUBAC serve as
scaffold for recruitment and retention of the TAB 2/3/TAB
1/TAK1 and NEMO/IKKa/IKKb kinase complexes
(Fig. 1). Recruitment of these complexes to the Ub chains
is mediated by the UBDs present in TAB 2/3 and NEMO,
respectively [29–32]. Whereas TAB 2/3 specifically binds
K63-linked poly-Ub chains, NEMO binds to M1-, K63-,
and K11-linked chains, yet with approximately 100-fold
higher affinity to M1-linked over K63- and K11-linked
chains [22, 30, 32–35]. Following activation, TAK1 acti-
vates the downstream MAPKs (JNK, p38 and ERK) and
IKKb by phosphorylation. IKKb in turn phosphorylates
IjBa, which leads to its K48-linked poly-ubiquitination by
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the Skp1-Cullin-F-box (SCF)/b-TRCP E3 complex and
results in proteasomal degradation of IjBa [36–39]. This
liberates the p50/RelA NF-jB dimer from IjBa-imposed
inhibition, and allows p50/RelA to translocate to the
nucleus where it drives expression of NF-jB target genes
(Fig. 1). The Ub-dependent signaling emerging from
complex I is negatively regulated by DUBs that mediate
disassembly of complex I by hydrolyzing the Ub modifi-
cations present in the complex. Some DUBs, such as A20
and Cezanne, are upregulated by TNF-induced NF-jB and
reported to be part of a negative feed-back mechanism
aimed at repressing NF-jB activation [40, 41]. A20 was
initially proposed to repress RIPK1-mediated NF-jB acti-
vation by functioning as a DUB removing the K63-linked
Ub chains from RIPK1, and as an E3 conjugating RIPK1
with K48-linked Ub chains promoting its proteasomal
degradation [41]. Several findings are now questioning the
validity of this model, such as the linkage specificity of its
DUB activity and, more importantly, the fact that mice
harboring mutations affecting A200s DUB or E3 activities
do not develop any signs of inflammation and are grossly
normal [42–45]. Other DUBs, such as CYLD and USP21,
are constitutively expressed and also implicated in regu-
lating TNFR1 signaling [46–49]. It was recently
demonstrated that CYLD is recruited to complex I via
direct binding to HOIP independently of LUBAC activity,
and that A20 directly binds to M1-linked Ub chains in
complex I, therefore requiring the E3 activity of LUBAC
for recruitment [28]. Once recruited, CYLD limits NF-jB
activation by removing K63-linked and M1-linked poly-Ub
chains on several components of complex I, including
RIPK1 [28, 47–50]. Interestingly, CYLD and A20 seem to
have opposing effect on M1-linked poly-Ub chain stability.
Whilst CYLD degrades them, A20 binds to them, thereby
preventing their cleavage and, hence, removal (Fig. 1)
[28]. Although the specific roles of all the individual DUBs
in complex I-dependent signaling are not yet fully under-
stood, the targeted recruitment of individual DUBs to
particular linkage types, together with their specificity in
hydrolyzing specific Ub linkages, likely serves to fine-tune
the precise extent and duration of signaling.
Role of poly-ubiquitination in regulating the two
TNFR1 complex I-dependent cell death
checkpoints
TNF-induced necroptosis is not the default cell death
pathway activated by TNFR1. Indeed, necroptosis only
occurs when caspase-8 activation fails or is inhibited,
indicating that caspase-8-mediated apoptosis actively
represses necroptosis [51–55]. Since any condition that
sensitizes to TNF-induced apoptosis will therefore also
sensitize to TNF-induced necroptosis when caspase-8 is
additionally inhibited, understanding how ubiquitination
regulates caspase-8 activation is therefore of great rele-
vance to comprehend TNF-induced necroptosis.
In most cases, TNFR1 engagement is insufficient to kill
cells but instead results in the ubiquitination-dependent
activation of gene induction through the NF-jB and MAPK
pathways (Fig. 2). However, when the NF-jB-dependent
response is inhibited, such as upon genetic deletion of NF-
jB, expression of a dominant-negative form of IjBa or in
the presence of transcriptional (actinomycin D) or trans-
lational (cycloheximide) inhibitors, cells succumb to
TNFR1 activation by TNF [56, 57]. Under these circum-
stances, the switch from a pro-survival to a pro-death
response involves the formation of a cytoplasmic caspase-
8-activating complex, known as TNFR1 complex II
(Fig. 2) [58, 59]. Complex II assembles when TRADD
dissociates from complex I and engages FADD in the
cytosol [14]. FADD in turn serves as a platform for the
recruitment and activation of caspase-8, resulting in
apoptotic cell death [60]. The transient formation of com-
plex II normally does not result in cell death since complex
I–dependent transcriptional upregulation of pro-survival
genes such as FLIP counteracts death induction from
complex II. FLIP is highly homologous to caspase-8 but
lacks catalytic activity and competes with caspase-8 for
recruitment to FADD in TNF complex II, thereby pre-
venting full caspase-8 activation.
It has now become clear that the NF-jB-dependent
induction of pro-survival genes is not the only cell death
checkpoint regulated by complex I, and that the role of
ubiquitination in preventing TNF-mediated cell death
exceeds canonical NF-jB activation [61]. Indeed, when
ubiquitination events in complex I are perturbed by the
absence of the E3 ligases cIAP1/2 or LUBAC, cells also
bFig. 1 TNFR1 complex I assembly and NF-jB activation. TNF
ligation to trimeric TNFR1 leads to recruitment of TRADD and
RIPK1 (1). TRAF2/5 and cIAP1/2 are then recruited to TRADD (2),
which allows cIAP1/2 to conjugate RIPK1 with Ub chains, including
K63-linked chains (3). The Ub chains added to RIPK1 then allow
further recruitment of the TAK1, IKK and LUBAC complexes via the
respective Ub binding domains of TAB 2/3, NEMO and HOIL/
Sharpin. Once recruited, LUBAC adds M1-linked Ub chains to
several complex I components, including RIPK1 and NEMO. This
leads to the recruitment of additional IKK complexes (4). Activated
TAK1 then activates IKKa/IKKb by phosphorylation (5). IKKb
subsequently phosphorylates IjBa at Ser32 and Ser36 (6) thereby
marking it for K48-linked ubiquitination and subsequent proteasomal
degradation (7). Released from IjBa inhibition, the p50/p65 NF-jB
transcription factor translocates to the nucleus to induce expression of
several pro-survival genes (8). Ubiquitination in TNFR1 complex I is
negatively regulated by LUBAC-recruited CYLD, which removes
both K63- and M1-linked Ub chains from several substrates,
including RIPK1 (9). In contrast, binding of A20 to M1-linked
chains stabilizes them by preventing their degradation (10)
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die after TNF stimulation due to increased formation of
complex II [19, 58, 62–66]. In this case, complex II for-
mation is highly dependent on RIPK1 and its kinase
activity. It is thought that the absence of cIAP1/2 or
LUBAC results in insufficient ubiquitination of RIPK1 in
complex I, which results in RIPK1 promoting the forma-
tion of complex II and cell death. (Fig. 2) [59]. In contrast
with complex II-mediated apoptosis induced by inhibiting
the NF-kB response downstream, which occurs indepen-
dently of RIPK1, the kinase activity of RIPK1 is crucial for
complex II assembly and apoptosis induction in the
absence of cIAP1/2 or LUBAC [58, 67, 68]. Therefore, to
distinguish these two different modes of inducing complex
II, the former is also called complex IIa, and the latter
complex IIb. In addition to apoptosis, deficiency in cIAP1/
2 or LUBAC also sensitizes cells to TNF-induced
necroptosis that is dependent on the kinase activity of
RIPK1 [11, 23, 64, 69, 70]. These findings indicated that
cIAP1/2 and LUBAC negatively regulate the pro-death
function of RIPK1 on top of promoting canonical NF-jB
activation. The Ub chains conjugated to RIPK1 by cIAP1/2
and LUBAC are therefore not only required to activate the
canonical NF-jB pathway but also to repress RIPK1
kinase-dependent death (Fig. 2). This concept is supported
by the fact that cells expressing a form of RIPK1 that is
mutated for its Ub acceptor site (K377R) undergo RIPK1-
dependent death following TNFR1 engagement by TNF
[31, 71]. Further supporting the notion that cIAP1/2
Fig. 2 Regulation of the different TNFR1 cell death checkpoints by
poly-ubiquitination. Left panel cIAP1/2- and LUBAC-mediated
ubiquitination of TNFR1 complex I components activates the IKK
complex. Active IKKa/b then promote cell survival by NF-jB-
dependent upregulation of pro-survival genes that counteract the
activation of the cytosolic apoptosis-inducing complex IIa (TRADD-
FADD-caspase-8). In addition, IKKa/b directly phosphorylate RIPK1
in complex I thereby preventing RIPK1 activation and, as a
consequence, RIPK1-mediated cell death (apoptosis and necroptosis).
Middle panel inhibition of the NF-jB pathway downstream of the
IKK complex, i.e. by an undegradable IjBa (IjBa-SR), the
transcription inhibitor actinomycin D (Act. D) or the translation
inhibitor cycloheximide (CHX), induces complex IIa-dependent
apoptosis. In this scenario, the active IKK complex still prevents
RIPK1 activation and RIPK1-mediated cell death (apoptosis and
necroptosis). Right panel cIAP1/2 or LUBAC deficiency impairs
TNF-induced activation of the IKK complex. As a result, the IKK-
mediated brake on RIPK1 is relieved. Active RIPK1 then promotes
assembly of complex IIb (RIPK1-FADD-caspase-8) resulting in
RIPK1-dependent apoptosis. Inhibition of caspase-8 shifts the cell
death modality from RIPK1-dependent apoptosis to RIPK1-depen-
dent necroptosis, induced by the necrosome (RIPK1/RIPK3/MLKL)
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regulate the pro-death function of RIPK1 directly is the
formation of the ‘ripoptosome’, a RIPK1-dependent cas-
pase-8-activating complex similar to complex II. However,
in contrast to complex II, it forms spontaneously (inde-
pendently from death receptors) when cIAP1/2 are
depleted [72, 73].
The importance of cIAP1/2- and LUBAC-mediated
ubiquitination in preventing uncontrolled RIPK1 activation
and consequent cell death has also been elegantly demon-
strated in a number of genetic mouse models. While the
genetic deletion of the catalytic component of LUBAC,
HOIP, is embryonically lethal at day E10.5, a null mutation
in the Sharpin gene is not lethal but instead results in the
development of a severe multi-organ inflammatory phe-
notype called chronic proliferative dermatitis (cpdm) [64,
74, 75]. These cpdm mice display severe inflammation in
the skin, liver, gut, lung and oesophagus, together with a
loss of Peyer’s patches and splenomegaly [74, 76]. The
inflammatory phenotype of cpdm mice is driven by aber-
rant TNFR1-mediated cell death [23, 65, 77]. Interestingly,
the cpdm phenotype can also be completely prevented by
crossing with RIPK1 kinase-dead knockin mice as well as
with the combination of RIPK3 deficiency and caspase-8
heterozygosity [65, 66]. These genetic studies confirm the
role of LUBAC-mediated ubiquitination in repressing
RIPK1 pro-death function and demonstrate that in the
absence of fully functional LUBAC, the kinase activity of
RIPK1 can both induce apoptosis and necroptosis in vivo.
The role of cIAP1/2 in vivo has been more difficult to study
as the single knock-outs do not show any overt phenotype
whereas the double knock-out, similar to the HOIP-/-
mice, causes embryonic lethality at day E10.5 due to car-
diovascular failure as a consequence of TNFR1-driven yolk
sac endothelial cell death [63, 78, 79]. Dysregulation of
RIPK1 in these knockouts has also been shown genetically
since deletion of RIPK1 slightly delays the lethality of
cIAP1-/- cIAP2-/- animals [63]. However, RIPK1 defi-
ciency on its own causes early postnatal lethality by
uncontrolled caspase-8-mediated apoptosis and RIPK3-
mediated necroptosis [80–82]. It would therefore be
interesting to test whether replacing wild-type RIPK1 by a
kinase-dead RIPK1 via gene knockin could prevent
embryonic lethality of cIAP1/2 or HOIP deficiency as this
would impair RIPK1’s pro-death function whilst keeping
its pro-survival scaffold function intact.
Importantly, CYLD repression was shown to protect
cells from TNF-mediated RIPK1 kinase-dependent apop-
tosis and necroptosis, which additionally supports the
notion that the K63- and M1-linked poly-Ub chains added
to complex I components by cIAP1/2 and LUBAC prevent
RIPK1 from initiating the formation of the cytosolic death
complex II [28, 50, 58, 67, 70]. Apart from functioning as
an inhibitor of the canonical NF-jB pathway, A20 is also
known as a potent inhibitor of TNF-induced apoptosis and
necroptosis, but the mechanism accounting for this func-
tion had remained unclear [69, 83, 84]. The recent finding
that A20 protects M1-linked poly-Ub chains from CYLD-
mediated degradation in complex I now provides a crucial
element in our understanding of the cell-protective function
of A20 [28].
It was initially believed that the Ub chains conjugated to
RIPK1 directly prevent RIPK1 from integrating into
complex IIb or the necrosome. More recent findings also
suggest that not only the Ub chains themselves, but also the
kinases recruited to them control RIPK1 kinase-dependent
death. Indeed, IKKa/IKKb were shown to prevent RIPK1
from integrating into complex IIb through direct phos-
phorylation in complex I, thereby suggesting a model
according to which IKKa/IKKb directly repress RIPK1
kinase activity (Fig. 2) [85]. In accordance with this model,
any conditions affecting IKKa/IKKb activation down-
stream of RIPK1 ubiquitination, such as deficiency in
TAK1, NEMO or IKKa/IKKb, were shown to sensitize
cells to RIPK1 kinase-dependent apoptosis and necroptosis
without affecting RIPK1 ubiquitination in complex I [67,
85–89]. Importantly, this role of IKKa/IKKb was demon-
strated to be independent of NF-jB activation.
Direct control of the necrosome
by poly-ubiquitination
Necroptosis induction was initially reported to occur fol-
lowing recruitment of RIPK3 to a RIPK1/FADD/caspase-8
complex, suggesting that the necrosome originates from an
inactive complex IIb. More recent papers however sug-
gested a model in which an independent RIPK1/RIPK3/
MLKL complex is formed in parallel to complex IIb [12].
The precise relation between complex IIb and the necro-
some is therefore currently unclear and additional work is
required to better define whether they represent two inde-
pendent complexes or variations of the same complex.
As mentioned in the previous section, poly-ubiquitina-
tion plays crucial roles in regulating necroptosis by
allowing complex I assembly and fine-tuning the two
complex-I-dependent cell death check points, namely the
NF-jB-dependent induction of pro-survival factors and the
NF-jB-independent contribution of RIPK1 to the cell
demise. Recent studies suggest that poly-ubiquitination
also plays a regulatory role at the level of the cell death-
inducing complex itself (Fig. 3). Indeed, TNFR1-induced
complex IIb/necrosome-associated components have been
reported to show post-translational modifications reminis-
cent of ubiquitination [67, 90–93]. Necrosome-associated
RIPK3 is conjugated with K63-linked poly Ub chains [91],
whereas RIPK1 has been reported to contain both M1- and
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K63-linked Ub chains [90, 93]. It is currently unclear
whether these ubiquitin chains regulate the cell death
outcome in a positive or negative manner, and whether
they additionally regulate a non-cell death signaling path-
way emanating from this complex. It appears that only a
fraction of the complex IIb/necrosome-associated RIPK1
(and RIPK3) is ubiquitinated, whereas all of the RIPK1
associated with TNFR1 complex I is ubiquitinated [67].
This difference in the amount of ubiquitinated RIPK1
molecules in both complexes may question the importance
of these post-translational modifications in the regulation
of the cell death complex itself. Indeed, it was demon-
strated that HOIP knockdown partially affects RIPK1
ubiquitination in the necrosome, while not affecting
necroptotic cell death significantly [93]. The identity of the
E3s ubiquitinating the different components of the
necrosome are still under debate, and it is not entirely clear
whether the poly-Ub chains conjugated to RIPK1 originate
from its ubiquitination in TNFR1 complex I. RIPK1
ubiquitination in the necrosome was reported to occur
independently of cIAP1/2 and only partially depending on
HOIP, which would suggest implication of additional E3s
[93]. In vitro studies have shown that cIAP1/2 are able to
add different types of poly-Ub chains to RIPK3, yet the
relevance of this observation for necroptotic signaling is
not established [94]. TRAF2 was also shown to bind to
MLKL in cells and was proposed to suppress TNF-induced
necroptosis by preventing MLKL to exert its pro-death
function [95]. Nevertheless, although MLKL was reported
to be ubiquitinated in cells, the suppressive function of
TRAF2 appears to occur independently of its supposed
activity as a Ub E3 [95, 96].
Fig. 3 Direct control of the necrosome by poly-ubiquitination.
Activated RIPK3 in the necrosome induces MLKL activation by
phosphorylation. Active MLKL then translocates to phosphatidyl
inositol phosphates in the plasma membrane. Plasma-membrane
associated MLKL oligomerizes into high-molecular weight com-
plexes and dysregulates the cellular ion homeostasis resulting in cell
swelling and plasma membrane rupture. Although the functional
relevance is not entirely clear at this time, RIPK1 and RIPK3 are
reported to be poly-ubiquitinated in the necrosome, presumably
independently of ubiquitination in TNFR1 complex I. RIPK1 is
associated with both M1-linked and K63-linked ubiquitin chains
while only K63-linked Ub chains have been described for RIPK3.
LUBAC and cIAP1/2 have been involved in the conjugation of these
Ub chains. From the DUB point of view, CYLD is reported to
promote necroptosis induction by removing the K63-linked Ub chains
on RIPK1. In contrast, A20 prevents necroptosis induction by
removing the K63-linked Ub chains on RIPK3
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Poly-ubiquitination at the level of the necrosome was
also demonstrated in studies making use of cells depleted
of the DUBs CYLD and A20. CYLD deficiency greatly
protects against TNF-induced necroptosis and this protec-
tion correlates with an increase in RIPK1 poly-
ubiquitination [28, 53, 70, 90]. Indeed, CYLD can hydro-
lyze M1- and K63-linked Ub chains conjugated to RIPK1
[28, 47–50]. Interestingly, Chan and colleagues showed
that CYLD-deficiency also affects ubiquitination of RIPK1
in the necrosome, which implies a role of CYLD in arming
RIPK1 in both, complex I and the necrosome [90]. In
contrast to CYLD, A20-deficient cells are strongly sensi-
tized to TNF-induced necroptosis and a recent study
associates this sensitization to increased RIPK3 poly-
ubiquitination in the necrosome [91]. In support of this
interpretation, the authors showed that mutation of Lys5 in
RIPK3 partially inhibited necrosome-associated RIPK3
poly-ubiquitination and TNF-induced necroptotic cell
death [91]. It is also of interest to note that absence of A20
does not only increase the amount of poly-ubiquitinated,
but also of non-ubiquitinated, RIPK3 in the necrosome.
This may be the result of an increased stability of the
necrosome in presence of poly-ubiquitinated RIPK3, or
reflective of the more upstream role of A20 in the pathway.
Indeed, A20 protects M1-linked poly-Ub chains in com-
plex I and thereby prevents RIPK1 from initiating the
formation of the cytosolic death-inducing complex II [28].
It is intriguing to note that ubiquitination of RIPK1 and
RIPK3 in the necrosome is reported to have opposite effect
on necroptosis induction. Those post-translational modifi-
cations would repress RIPK1 but activate RIPK3. Future
work on the identification of the type of Ub chains con-
jugated to each protein is clearly needed to provide a
molecular basis for the better understanding of these
apparent opposing consequences. Also, uncoupling com-
plex I from necrosome assembly may help evaluating the
respective contribution of the different E3s and DUBs to
the two different steps of the pathway. It might, for
example, be interesting to study how the presence or
absence of these enzymes affects necroptosis induced by
forced homo- and heterodimerization of RIPK1 and
RIPK3.
Concluding remarks
In recent years, great advances have been made in the
understanding of the molecular mechanisms of TNFR1-
induced necroptosis. However, the exact consequences,
functions and interconnections between the diverse post-
translational modifications regulating this signaling path-
way still remain to be investigated in more detail. Although
ubiquitination has clearly emerged as a major regulatory
mechanism, the identity of all the substrates, the exact
linkage composition of the different poly-Ub chains, the
precise roles of the diverse Ub-related enzymes and their
specificity for complex I vs. complex II/necrosome still
require better understanding. Most of the knowledge
acquired over the past years has been generated by the use
of cutting-edge biochemistry, often combined with
sophisticated in- vivo models employing component-defi-
cient mice and/or cells. It is now important to understand
how the activities of the ubiquitination-modifying enzymes
are regulated under physiological conditions and how this
is deregulated in pathological conditions. It is for example
known that binding of TNF to TNFR2 induces degradation
of a pool of TRAF2/cIAP1/cIAP2 that consequently affects
ubiquitination in TNFR1 complex I and switches the
TNFR1-mediated response from survival to death [97]. Co-
stimulation with other members of the TNFR superfamily
can exert similar effects. What are, however, the conditions
that regulate other ubiquitination-modifying enzymes? A
possible hint comes from the fact that necroptosis is often
associated with the generation of ROS and that the activity
of A20 and other OTU deubiquitinases was shown to be
regulated by reversible oxidation [98]. Also, viral infection
can trigger necroptosis and some viruses have been
reported to interfere with the enzymatic activities of
endogenous E3s and DUBs [99, 100].
RIPK1 plays a pivotal role in determining the cellular
response to TNF. While it functions as a central signaling
platform in the TNFR1 complex I to drive NF-jB- and
MAPK-mediated cell survival and inflammation, it also
plays a crucial role in the cytosolic complex II and, con-
sequently, in the induction of cell death. In accordance,
ubiquitination of RIPK1 in both complexes is a key event
in regulating the TNFR1 signaling pathway to necroptosis.
Nevertheless, necroptosis induced by receptors other than
TNFR1, such as TLR3 and DAI, does not require RIPK1.
Downstream of these receptors, the RHIM domain required
to recruit and activate RIPK3 is respectively provided by
TRIF or DAI itself [101–104]. Studying the role of E3s and
such as cIAP1/2 and LUBAC as well as DUBs such as A20
and CYLD in the ubiquitination-dependent regulation of
necroptosis downstream of these receptors are therefore
interesting perspectives.
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